Articles de revue sur le cancer du pancréas - Derni ères parutions

InTextoResearch, agence d'information scientifique


InTextoResearch vous informe sur les dernières parutions d'articles de
revue sur le cancer du pancreas (30 mai 2008):

Targeting of extracellular proteases required for the progression of
pancreatic cancer.
Ardito CM, Briggs CD, Crawford HC.
Expert Opin Ther Targets. 2008 May;12(5):605-19.

Is there a role for advanced radiation therapy technologies in the
treatment of pancreatic adenocarcinoma?
Meyer JJ, Willett CG, Czito BG.
Future Oncol. 2008 Apr;4(2):241-55.

Gemcitabine in the treatment of metastatic pancreatic cancer.
Hilbig A, Oettle H.
Expert Rev Anticancer Ther. 2008 Apr;8(4):511-23.

Metastatic disease to the pancreas and spleen.
Showalter SL, Hager E, Yeo CJ.
Semin Oncol. 2008 Apr;35(2):160-71.

The role of nuclear factor kappaB in pancreatic cancer and the
clinical applications of targeted therapy.
Holcomb B, Yip-Schneider M, Schmidt CM.
Pancreas. 2008 Apr;36(3):225-35.

Current status of gene expression profiling of pancreatic cancer.
Goonetilleke KS, Siriwardena AK.
Int J Surg. 2008 Feb;6(1):81-3.

Pancreatic cancer: a review of the evidence on causation.
Hart AR, Kennedy H, Harvey I.
Clin Gastroenterol Hepatol. 2008 Mar;6(3):275-82.

Intraductal papillary-mucinous neoplasms: a new and evolving entity
among the pancreatic tumors.
Klöppell G, Kosmahl M, Sipos B.
Verh Dtsch Ges Pathol. 2007;91:66-73.

Nonfunctioning pancreatic endocrine neoplasm presenting as
asymptomatic, isolated pancreatic duct stricture: a case report and
review of the literature.
Powell AC, Hajdu CH, Megibow AJ, Shamamian P.
Am Surg. 2008 Feb;74(2):168-71.

New aspects of regulatory signaling pathways and novel therapies in
pancreatic cancer.
Diamantidis M, Tsapournas G, Kountouras J, Zavos C.
Curr Mol Med. 2008 Feb;8(1):12-37.

Genetic adjuvant therapy for pancreatic cancer and other solid
tumours.
Bagley KC.
Gut. 2008 Mar;57(3):289-91.

Molecular genetics of pancreatic ductal adenocarcinomas and recent
implications for translational efforts.
Feldmann G, Maitra A.
J Mol Diagn. 2008 Mar;10(2):111-22.

The role of second-line chemotherapy after gemcitabine failure in
patients with advanced pancreatic cancer.
Boeck S, Heinemann V.
Future Oncol. 2008 Feb;4(1):41-50.

Familial pancreatic cancer: a review and latest advances.
Grocock CJ, Vitone LJ, Harcus MJ, Neoptolemos JP, Raraty MG, Greenhalf
W.
Adv Med Sci. 2007;52:37-49.

The role of adjuvant chemotherapy for patients with resected
pancreatic cancer: systematic review of randomized controlled trials
and meta-analysis.
Boeck S, Ankerst DP, Heinemann V.
Oncology. 2007;72(5-6):314-21.


(contact pour InTextoResearch: Marc Lacroix, Baelen, Wallonie,
Belgique - scimedweb@mail.com)